Mallinckrodt plc
USD0.02
+0.00 (+0.00%)
CEO
Mark Christopher Trudeau
IPO Date
2013-06-17
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
IE
Open
$0.02
Prev. Close
$0.02
Day Low
$0.02
Day High
$0.02
52W Low
$0.00
52W High
$0.36
Volume
0.29M
| 0.0 |
| 29 Dec 2023 | FY | 68.5% | -6.0% | 0.0% | 0.0% | 0.00 | 0.00 | -2.2 |
| 30 Dec 2022 | FY | 40.4% | -32.5% | -44.5% | -11.9% | 1.90 | 2.74 | -1.9 |
| 31 Dec 2021 | FY | 40.4% | -32.8% | -230.9% | -8.1% | 4.43 | 1.19 | -1.8 |
| 31 Dec 2020 | FY | 30.2% | -43.8% | -95.1% | -10.0% | 3.52 | 0.56 | -1.3 |
| 31 Dec 2019 | FY | 44.9% | -31.8% | -51.9% | -9.7% | 2.77 | 1.28 | -1.3 |
| 31 Dec 2018 | FY | 45.8% | -112.2% | -124.9% | -33.2% | 2.11 | 1.51 | -0.4 |
| 31 Dec 2017 | FY | 51.4% | 66.3% | 32.7% | 14.0% | 1.03 | 2.18 | 0.7 |
| 30 Sept 2016 | FY | 54.9% | 19.0% | 12.2% | 4.2% | 1.15 | 1.22 | 2.7 |
| -0.0 |
| 26 Sept 2025 | Q3 | 33.7% | -38.7% | -9.2% | -3.4% | 1.18 | 3.23 | -0.0 |
| 27 Jun 2025 | Q2 | 47.8% | 0.5% | 0.1% | 0.1% | 0.55 | 3.54 | 0.2 |
| 28 Mar 2025 | Q1 | 48.3% | -6.6% | -1.7% | -0.8% | 0.56 | 3.57 | -0.0 |
| 27 Dec 2024 | Q4 | 40.7% | 60.1% | 32.6% | 16.3% | 0.55 | 3.78 | 0.0 |
| 27 Sept 2024 | Q3 | 43.7% | -5.2% | -2.5% | -0.7% | 1.69 | 3.11 | -0.0 |
| 28 Jun 2024 | Q2 | 37.9% | -8.4% | -4.1% | -1.2% | 1.67 | 3.43 | -0.0 |
| 29 Mar 2024 | Q1 | 71.9% | 16.0% | 0.0% | 0.0% | 0.00 | 0.00 | 0.6 |
| 29 Dec 2023 | Q4 | 7.4% | -130.8% | 0.0% | 0.0% | 0.00 | 0.00 | 0.0 |